Skip to main content
Equibles
HR logo

HR · Healthcare Realty Trust Inc · Metrics

Track HR — free

Use HR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.44 +0.26 (+1.36%) At close · Nov 4 Play latest call Q3 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$6.58B
Shares
338.54M
Volume · Nov 4 6.93M Avg daily vol (3M) 4.57M

HR metrics

89 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$19.44
Market cap
$6.58B

Price action

20 metrics
Price change (1W)
+7.2%
Price change (30D)
+12.3%
Price change (3M)
-5.4%
Price change (6M)
-3.7%
Price change (YTD)
+13.2%
Price change (1Y)
+8.8%
Trailing year
Price change (5Y)
-42.3%
52-week high
$21.87
52-week low
$16.34
Change from 52-week high
-12.3%
Change from 52-week low
+17.4%
Annualized volatility
20.2%
Annualized volatility (3M)
21.2%
Beta
0.1
RSI (14D)
67.2
Price vs SMA 50
+5.6%
Price vs SMA 200
+1.7%
Avg volume (3M)
4.52M
Relative volume
1.6
Average dollar volume
$82.98M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
338.54M

Valuation

14 metrics
P / FFO
11.3×
Company-stated · TTM · reciprocal yield 8.9%
P / AFFO
11.5×
Company-stated · FY2025 · reciprocal yield 8.7%
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
9.5×
reciprocal yield 10.6%
EV / EBITDA
20.8×
reciprocal yield 4.8%
EV / EBIT
61.8×
reciprocal yield 1.6%
P / sales
5.7×
reciprocal yield 17.5%
P / book
1.6
reciprocal yield 62.8%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
14.4
reciprocal yield 6.9%
Earnings yield
-0.7%

Historical valuation

8 metrics
P / E historical average (3Y)
133.3×
reciprocal yield 0.8%
P / E historical average (5Y)
133.3×
reciprocal yield 0.8%
EV / revenue historical average (3Y)
8.7×
reciprocal yield 11.6%
EV / revenue historical average (5Y)
10.2×
reciprocal yield 9.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
5.0%
Trailing 12 months
Payout ratio
—
Shareholder yield
5.2%
Dividend / share (TTM)
$0.96
Dividend growth YoY
-17.9%
Dividend growth streak
0
Last ex-dividend
2026-08-11

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-30

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
-4.0%
Gross profit (TTM)
—
Operating profit (TTM)
$143.69M
Net income (TTM)
−$44.93M
Trailing 12 months
Diluted EPS (TTM)
$-0.14
FCF margin
—
Effective tax rate
—

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$3.29
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$0.68
EBITDA per diluted share (TTM)
$2.02
Net income per diluted share (TTM)
$-0.13
Operating cash flow per diluted share (TTM)
$1.30
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$13.13

Growth

11 metrics
Revenue growth YoY
-3.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.13B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-2.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+8.2%
Revenue CAGR (5Y)
+18.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-19.5%
FCF CAGR (5Y)
-3.4%

Quality

14 metrics
Return on equity
-1.1%
Return on assets
-0.5%
Debt / equity
1.0
Current ratio
—
EBITDA (TTM)
$425.84M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
5.6
Return on invested capital
—
Trailing 12 months
Net cash
−$4.23B
Latest balance sheet
Cash & equivalents
$17.50M
Total assets
$8.96B
Total debt
$4.25B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$449.69M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$17.76M
R&D / revenue
—
Stock compensation / revenue
1.6%

Ownership (13F)

9 metrics
13F filers
465
13F filer change QoQ
+13
Institutional ownership
113.0%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.9%
Holder tenure
11.2
Price vs estimated holder cost
-2.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
26.7%

Short interest

3 metrics
Short interest
5.2%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$401,310
Insider-sentiment score
44 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1360604 CUSIP 42226K105 13F (30d) 177 filings 159 filers Visit website Investor relations